These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2443554)
1. Cytoskeletal alterations leading to Mallory body formation in livers of mice fed 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Tsunoo C; Harwood TR; Arak S; Yokoo H J Hepatol; 1987 Aug; 5(1):85-97. PubMed ID: 2443554 [TBL] [Abstract][Full Text] [Related]
2. Experimental production of Mallory bodies in mice by diet containing 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Yokoo H; Harwood TR; Racker D; Arak S Gastroenterology; 1982 Jul; 83(1 Pt 1):109-13. PubMed ID: 6176493 [TBL] [Abstract][Full Text] [Related]
3. Relationship of Mallory bodies to the cytoskeleton of hepatocytes in griseofulvin-treated mice. Irie T; Benson NC; French SW Lab Invest; 1982 Oct; 47(4):336-45. PubMed ID: 6889660 [TBL] [Abstract][Full Text] [Related]
4. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130 [TBL] [Abstract][Full Text] [Related]
5. Excretory function in cultured hepatocytes from griseofulvin-treated mice. Kawahara H; Marceau N; French SW Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150 [TBL] [Abstract][Full Text] [Related]
6. Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver. Hutter H; Zatloukal K; Winter G; Stumptner C; Denk H Lab Invest; 1993 Nov; 69(5):576-82. PubMed ID: 7504119 [TBL] [Abstract][Full Text] [Related]
7. Bile acid-induced Mallory body formation in drug-primed mouse liver. Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H Am J Pathol; 2002 Dec; 161(6):2019-26. PubMed ID: 12466118 [TBL] [Abstract][Full Text] [Related]
8. Relationship of Mallory bodies to intermediate filaments in hepatocytes. A scanning electron microscopy study. Okanoue T; Ohta M; Ou O; Kachi K; Kagawa K; Yuki T; Okuno T; Takino T; French SW Lab Invest; 1985 Nov; 53(5):534-40. PubMed ID: 2414564 [TBL] [Abstract][Full Text] [Related]
9. Rearrangement of the hepatocyte cytoskeleton after toxic damage: involution, dispersal and peripheral accumulation of Mallory body material after drug withdrawal. Denk H; Franke WW Eur J Cell Biol; 1981 Feb; 23(2):241-9. PubMed ID: 7193580 [TBL] [Abstract][Full Text] [Related]
10. Fate of Mallory body-containing hepatocytes: disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin-treated mouse. Zatloukal K; Spurej G; Rainer I; Lackinger E; Denk H Hepatology; 1990 Apr; 11(4):652-61. PubMed ID: 1691733 [TBL] [Abstract][Full Text] [Related]
11. Cytokeratin intermediate filaments of rat hepatocytes: different cytoskeletal domains and their three-dimensional structure. Katsuma Y; Marceau N; Ohta M; French SW Hepatology; 1988; 8(3):559-68. PubMed ID: 2453432 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of Mallory body, intermediate filament, and microfilament proteins in liver cell primary cultures. An electron microscopic autoradiography assay. Kachi K; Cadrin M; French SW Lab Invest; 1993 Jan; 68(1):71-81. PubMed ID: 7678660 [TBL] [Abstract][Full Text] [Related]
13. Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation. Harada M; Strnad P; Resurreccion EZ; Ku NO; Omary MB Hepatology; 2007 Jan; 45(1):88-96. PubMed ID: 17187412 [TBL] [Abstract][Full Text] [Related]
14. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. Katsuma Y; Swierenga SH; Khettry U; Marceau N; French SW Hepatology; 1987; 7(6):1215-23. PubMed ID: 2445643 [TBL] [Abstract][Full Text] [Related]
15. Maintenance of desmosomes in mouse hepatocytes after drug-induced rearrangement of cytokeratin filament material. Demonstration of independence of desmosomes and intermediate-sized filaments. Denk H; Lackinger E; Cowin P; Franke WW Exp Cell Res; 1985 Nov; 161(1):161-71. PubMed ID: 2414118 [TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. Zatloukal K; Stumptner C; Lehner M; Denk H; Baribault H; Eshkind LG; Franke WW Am J Pathol; 2000 Apr; 156(4):1263-74. PubMed ID: 10751352 [TBL] [Abstract][Full Text] [Related]
17. The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury. Hanada S; Strnad P; Brunt EM; Omary MB Hepatology; 2008 Sep; 48(3):943-52. PubMed ID: 18697208 [TBL] [Abstract][Full Text] [Related]
18. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products. Preisegger KH; Stumptner C; Riegelnegg D; Brown PC; Silverman JA; Thorgeirsson SS; Denk H Hepatology; 1996 Jul; 24(1):248-52. PubMed ID: 8707270 [TBL] [Abstract][Full Text] [Related]
19. Mallory body filaments become insoluble after normal assembly into intermediate filaments. Pollanen MS; Markiewicz P; Weyer L; Goh MC; Bergeron C Am J Pathol; 1994 Nov; 145(5):1140-7. PubMed ID: 7526693 [TBL] [Abstract][Full Text] [Related]
20. Sequence of events in the assembly of Mallory body components in mouse liver: clues to the pathogenesis and significance of Mallory body formation. Stumptner C; Fuchsbichler A; Lehner M; Zatloukal K; Denk H J Hepatol; 2001 May; 34(5):665-75. PubMed ID: 11434612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]